NICE's severity modifiers misalign with public preferences in England & Wales, prioritising health gains at lower disease ...

More collaborative initiatives are taking place among regulatory agencies, health technology assessment (HTA) bodies and ...

Stuart Carroll is a senior health economist and epidemiologist with over 18 years of experience, specialising in infectious diseases and vaccines, market access, health technology appraisal, public ...